Hypotension Prediction 2 Study in Cardiac Surgery and Postoperative ICU Admission (HYPE-2)

Effect of a Machine Learning-Derived Early Warning System for Hypotension vs Standard Care on Depth and Duration of Intra- and Postoperative Hypotension in Elective Cardiac Surgery

This trial registration serves as an amendment incorporating the IPD Sharing Statement.

This study already has a trial registration (2021 April 30) in the Netherlands Trial Registry (Reference number NL9449, https://trialsearch.who.int/). However, the NTR register is subject to a merger with another Dutch register. This means that existing registrations are still visible, but can no longer be adjusted.

Study summary:

Hypotension in the operating room (OR) and during post-operative ICU admission is common in surgical patients and even more prevalent in cardiac surgery patients. It is associated with adverse outcomes and while these events are preventable, current management is predominantly reactive. Edwards Lifesciences (Irvine, CA) has developed the Hypotension Prediction Index (HPI), an early warning system that predicts an hypotensive event, defined as MAP below 65 mmHg, with high accuracy minutes before it occurs. At the time of writing the protocol this model has not been tested in a clinical trial in cardiac surgery patients or ICU admitted patients. The aim of the HYPE-2 trial is to assess whether the HPI-algorithm can reduce the time-weighted average (TWA) of intra- and postoperative hypotension in elective on-pump coronary artery bypass graft (CABG) surgery patients.

Study Overview

Detailed Description

Population studied:

All adult patients undergoing elective on-pump CABG surgery or CABG with additional single heart valve surgery (e.g. valve repair or replacement), requiring a radial arterial line and an intended target MAP of 65 mmHg or above during both surgery (excluding cardiopulmonary bypass pump time (CBP)) and during mechanically ventilated phase of duration of ICU admission.

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord-Holland
      • Amsterdam-Zuidoost, Noord-Holland, Netherlands, 1105 AZ
        • Amsterdam University Medical Centers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 years or older at inclusion
  • Planned for elective on-pump CABG surgery or CABG with additional single heart valve surgery (e.g. valve repair or replacement)
  • Planned to receive standard monitoring for cardiac surgery
  • Target MAP of 65 mmHg or above during surgery
  • Target MAP of 65 mmHg or above during the mechanically ventilated phase of ICU admission

Exclusion Criteria:

  • Known cardiac shunts (significant)
  • Severe cardiac arrhythmias (including but not limited to persistent atrial fibrillation prior to surgery)
  • Expected to receive an hemodynamic assist device (e.g. intra-aortic balloon pump) during surgery
  • Dialysis dependent kidney failure prior to surgery
  • Planned to receive Perioperative Goal Directed Therapy (PGDT) other than standard intraoperative care
  • Previous cardiac surgery in medical history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group

Objective to maintain a mean arterial blood pressure (MAP) above or equal to 65 mm Hg, as is standard care in out institution.

This is done using standard hemodynamic monitoring, which in our center consists of continuous arterial blood pressure monitoring and the pulse pressure variation parameter. The clinician will administer either fluids, inotropes, vasopressors, or a combination, or apply positional changes to maintain the set MAP threshold.

Experimental: Additional HPI guided treatment

Objective to maintain a mean arterial blood pressure (MAP) above or equal to 65 mm Hg, as is standard care in out institution.

This is done using standard hemodynamic monitoring (as described for the control group) but is assisted by the Hypotension Prediction Index (HPI). This parameter is made available to the clinicians with the HemoSphere Advanced Monitoring Platform (HemoSphere) and is used to initiate treatment when the HPI values is ≥ 75.

It also provides additional advanced hemodynamic variables (e.g. cardiac output, systemic vascular resistance). The treating clinicians are trained to use these variables and are provided with a diagnostic flowchart to determine the cause (preload, contractility and afterload) of the upcoming hypotensive (MAP < 65 mmHg) event. Timing of treatment and choice of treatment is then left to the discretion of the attending clinician.

Administer hemodynamic altering intervention aimed at either a preload, contractility, or afterload problem to prevent impending hypotension. Treatment options include: administering either fluids, inotropes, vasopressors, positional changes, or a combination.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The overall time-weighted average (TWA) of hypotension (severity of hypotension)
Time Frame: During both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA is a calculation of the depth (in mmHg) of hypotension below the 'threshold' MAP of 65 mmHg x the time spent in hypotension in minutes, this resulting in an 'area'. To better compare this value between different patients the 'area' can be divided by the total duration of the measurement.
During both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of hypotension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
number of hypotensive events during study phases
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Time spent in hypotension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in minutes spent in hypotension during study phases
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
The percentage of time in hypotension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in hypotension expressed in percentage of the total study phases' duration
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
The AUT of a MAP < 65 mmHg
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
AUT is a calculation of the depth (in mmHg) of hypotension below the 'threshold' MAP of 65 mmHg x the time spent in hypotension in minutes, this resulting in an 'area'.
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Incidence of hypertension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
number of hypertensive events during study phases
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Time spent in hypertension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in minutes spent in hypertension during study phases
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
The percentage of time in hypertension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in hypertension expressed in percentage of the total study phases' duration
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
The AAT of a MAP > 100 mmHg
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
AAT is a calculation of the depth (in mmHg) of hypertension above the 'threshold' MAP of 100 mmHg x the time spent in hypertension in minutes, this resulting in an 'area'.
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA of hypertension
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA is a calculation of the depth (in mmHg) of hypertension above the 'threshold' MAP of 100 mmHg x the time spent in hypertension in minutes, this resulting in an 'area'. This 'area' is divided by the total duration of the measurement.
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Incidence of HPI alarm (HPI ≥ 75)
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
number of HPI alarms during study phases
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Time spent in HPI alarm
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in minutes spent in HPI alarms during study phases
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
The percentage of time in HPI alarm
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in HPI alarms expressed in percentage of the total study phases' duration
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
The AAT of a HPI ≥ 75
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
AAT is a calculation of the depth of HPI above or equal to the 'threshold' of 75 x the time spent in HPI alarm in minutes, this resulting in an 'area'.
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA of HPI alarm
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA is a calculation of the depth of HPI above or equal to the 'threshold' of 75 x the time spent in HPI alarm in minutes, this resulting in an 'area'. This 'area' is divided by the total duration of the measurement.
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Treatment choice
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
vasopressors, blood transfusions, fluids, inotropes, position changes, decrease in anesthetics
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Treatment dose
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Dosage of medication or volume of fluids
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Time to treatment
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
If an alarm or hypotensive event had more than 1 treatment, the time to first treatment will be used.
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Number of treatments
Time Frame: Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of treatments (e.g., administered fluids, vasopressors, inotropes, anesthetics) given to alter the hemodynamics (increase of reduce the blood pressure)
Will be analyzed for the overall duration of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of hypertension (intraoperative)
Time Frame: During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
number of hypertensive events during the intraoperative study phases
During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Incidence of hypertension (postoperative in the ICU)
Time Frame: During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
number of hypertensive events during the ICU study phase
During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Time spent in hypertension (intraoperative)
Time Frame: During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
amount of time in minutes spent in hypertension during the intraoperative study phases
During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Time spent in hypertension (postoperative in the ICU)
Time Frame: During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in minutes spent in hypertension during the ICU study phase
During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA of hypertension (intraoperative)
Time Frame: During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
TWA is a calculation of the depth (in mmHg) of hypertension above the 'threshold' MAP of 100 mmHg x the time spent in hypertension in minutes, this resulting in an 'area'. This 'area' is divided by the total duration of the measurement.
During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
TWA of hypertension (postoperative in the ICU)
Time Frame: During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA is a calculation of the depth (in mmHg) of hypertension above the 'threshold' MAP of 100 mmHg x the time spent in hypertension in minutes, this resulting in an 'area'. This 'area' is divided by the total duration of the measurement.
During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Incidence of HPI alarm (HPI ≥ 75) (intraoperative)
Time Frame: During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
number of HPI alarms during the intraoperative study phases
During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Incidence of HPI alarm (HPI ≥ 75) (postoperative in the ICU)
Time Frame: During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
number of HPI alarms during the ICU study phase
During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Time spent in HPI alarm (intraoperative)
Time Frame: During both the off-pump phases of on-pump CABG surgery (up to 8 hours)
amount of time in minutes spent in HPI alarms during the intraoperative study phases
During both the off-pump phases of on-pump CABG surgery (up to 8 hours)
Time spent in HPI alarm (postoperative in the ICU)
Time Frame: During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
amount of time in minutes spent in HPI alarms during the ICU study phase
During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA of HPI alarm (intraoperative)
Time Frame: During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
TWA is a calculation of the depth of HPI above or equal to the 'threshold' of 75 x the time spent in HPI alarm in minutes, this resulting in an 'area'. This 'area' is divided by the total duration of the measurement.
During both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
TWA of HPI alarm (postoperative in the ICU)
Time Frame: During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
TWA is a calculation of the depth of HPI above or equal to the 'threshold' of 75 x the time spent in HPI alarm in minutes, this resulting in an 'area'. This 'area' is divided by the total duration of the measurement.
During the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Compliance of clinicians to HPI treatment protocol + diagnostic guidance
Time Frame: Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)

Assessed by the number of- and reason for protocol deviations: ignored treatment advices.

The nurse driven hypotension treatment protocol only applies to the ICU nurses

Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Association between decrease in TWA of hypotension and a difference in creatinine (μmol/L)
Time Frame: Admission at ICU admission, and every morning of hospitalization after surgery (up to 28 days)
Difference in laboratory value of creatinine between the control and HPI guided treatment group after the surgical procedure
Admission at ICU admission, and every morning of hospitalization after surgery (up to 28 days)
Association between decrease in TWA of hypotension and a difference in lactate (mmol/L)
Time Frame: All lactate samples taken during the study phases and the samples taken every morning during ICU admission (up to 28 days)
Difference in laboratory value of lactate between the control and HPI guided treatment group
All lactate samples taken during the study phases and the samples taken every morning during ICU admission (up to 28 days)
Association between decrease in TWA of hypotension and a difference in creatinine kinase MB (μg/L)
Time Frame: During ICU admission (up to 28 days)
Difference in laboratory value of creatinine kinase MB between the control and HPI guided treatment group
During ICU admission (up to 28 days)
Association between decrease in TWA of hypotension and a difference in hematocrit (L/L)
Time Frame: During ICU admission (up to 28 days)
Difference in laboratory value of hematocrit between the control and HPI guided treatment group
During ICU admission (up to 28 days)
Association between decrease in TWA of hypotension and a difference in central venous oxygen saturation (%)
Time Frame: All samples taken during the study phases until the first sample after extubation at ICU (up to 28 days)
Difference in laboratory value of central venous oxygen saturation between the control and HPI guided treatment group
All samples taken during the study phases until the first sample after extubation at ICU (up to 28 days)
Association between decrease in TWA of hypotension and a difference in brain natriuretic peptide (ng/L)
Time Frame: During ICU admission (up to 28 days)
Difference in laboratory value of brain natriuretic peptide between the control and HPI guided treatment group
During ICU admission (up to 28 days)
Sustained effect on TWA of hypotension
Time Frame: After HPI and diagnostic guidance is disconnected up to 8 hours after discontinuation.
To study whether reducing the severity of hypotension with HPI and diagnostic guidance during both the surgery and the first hours of ICU admission results in a sustained effect after discontinuation of the HPI guided treatment.
After HPI and diagnostic guidance is disconnected up to 8 hours after discontinuation.
Sustained effect on incidence of hypotension
Time Frame: After HPI and diagnostic guidance is disconnected up to 8 hours after discontinuation.
To study whether reducing the severity of hypotension with HPI and diagnostic guidance during both the surgery and the first hours of ICU admission results in a sustained effect after discontinuation of the HPI guided treatment.
After HPI and diagnostic guidance is disconnected up to 8 hours after discontinuation.
Sustained effect on time spent in hypotension
Time Frame: After HPI and diagnostic guidance is disconnected up to 8 hours after discontinuation.
To study whether reducing the severity of hypotension with HPI and diagnostic guidance during both the surgery and the first hours of ICU admission results in a sustained effect after discontinuation of the HPI guided treatment.
After HPI and diagnostic guidance is disconnected up to 8 hours after discontinuation.
Difference in treatment behaviour between groups expressed as total number of alarms (n)
Time Frame: Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
To study control group's treatment behaviour after silent alarms to which they were blinded and compare this with treatment behaviour after alarms in the HPI guided treatment group. This analysis focusses on the number of treatments after an early warning system alarm (referred to as 'alarm') but before hypotension occurred. In the HPI guided treatment group the alarms were visible to the treating anesthesiologists. In the control group the alarms were not visible to the treating anesthesiologists. The researchers will compare the total number of alarms (n) between both groups.
Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Difference in treatment behaviour between groups expressed as number of alarms per patients (n)
Time Frame: Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
To study control group's treatment behaviour after silent alarms to which they were blinded and compare this with treatment behaviour after alarms in the HPI guided treatment group. This analysis focusses on the number of treatments after an early warning system alarm (referred to as 'alarm') but before hypotension occurred. In the HPI guided treatment group the alarms were visible to the treating anesthesiologists. In the control group the alarms were not visible to the treating anesthesiologists. The researchers will compare the number of alarms per patients (n) between both groups.
Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Difference in treatment behaviour between groups expressed as total percentage of alarms treated (%)
Time Frame: Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
To study control group's treatment behaviour after silent alarms to which they were blinded and compare this with treatment behaviour after alarms in the HPI guided treatment group. This analysis focusses on the number of treatments after an early warning system alarm (referred to as 'alarm') but before hypotension occurred. In the HPI guided treatment group the alarms were visible to the treating anesthesiologists. In the control group the alarms were not visible to the treating anesthesiologists. The researchers will compare the total percentage of alarms treated (%) for each group.
Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Difference in treatment behaviour between groups expressed as time from alarm to first treatment action (seconds).
Time Frame: Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
To study control group's treatment behaviour after silent alarms to which they were blinded and compare this with treatment behaviour after alarms in the HPI guided treatment group. This analysis focusses on the number of treatments after an early warning system alarm (referred to as 'alarm') but before hypotension occurred. In the HPI guided treatment group the alarms were visible to the treating anesthesiologists. In the control group the alarms were not visible to the treating anesthesiologists. The researchers will compare the time from alarm occurrences to first treatment action (seconds).
Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Difference in treatment behaviour between groups expressed as time from first alarm to first treatment action (seconds).
Time Frame: Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
To study control group's treatment behaviour after silent alarms to which they were blinded and compare this with treatment behaviour after alarms in the HPI guided treatment group. This analysis focusses on the number of treatments after an early warning system alarm (referred to as 'alarm') but before hypotension occurred. In the HPI guided treatment group the alarms were visible to the treating anesthesiologists. In the control group the alarms were not visible to the treating anesthesiologists. The researchers will compare the time from first alarm to first treatment action (seconds).
Will be analyzed for all study phases of both the off-pump phases of on-pump CABG surgery and the mechanically ventilated phase of post-operative ICU admission (or 8 hours maximum)
Assess required treatment during hypotension (MAP < 65 mmHg) within both off-pump phases of on-pump CABG surgery as the determined by the anesthesiologist based on transesophageal echocardiogram (TEE) observations.
Time Frame: During hemodynamic instability (hypotension) within both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Anesthesiologists have the expertise to use TEE observations during hypotensive events to obtain insight in the most likely cause of hypotension: hypovolemia, vasoplegia or reduced ventricular contractility. Each time these observations are obtained the researchers will annotate the determined required treatment.
During hemodynamic instability (hypotension) within both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Assess required treatment during hypotension (MAP < 65 mmHg) within both off-pump phases of on-pump CABG surgery as the determined by the diagnostic guidance protocol.
Time Frame: During hemodynamic instability (hypotension) within both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Prior to the start of the study the researchers designed a diagnostic guidance protocol that integrates parameters obtained from the HemoSphere monitor (i.e., stroke volume, stroke volume variation, systemic vascular resistance, and Dynamic arterial elastance). These parameters provide insight in the most likely cause of forthcoming hypotension: hypovolemia, vasoplegia or reduced ventricular contractility. During hemodynamic instability and hypotension the diagnostic guidance protocl is used to determine the required treatment and will be annotated.
During hemodynamic instability (hypotension) within both the off-pump phases of on-pump CABG surgery (or 8 hours maximum)
Relation between required treatment as determined by the anesthesiologist's expertise using TEE observations versus the required treatment as determined using the diagnostic guidance protocol.
Time Frame: During hemodynamic instability within both the off-pump phases of on-pump CABG surgery (up to 8 hours)
As described in the outcome measures 46 and 47, the researchers will assess the required treatments during hemodynamic instability and hypotension. These treatments are determined by the anesthesiologists using TEE observations and simultaneously also by the researchers using the study's diagnostic guidance protocol. Both diagnostic strategies will determine the same treatment options, namely: hypovolemia, vasoplegia or reduced ventricular contractility. The researchers will assess the number of devations in determined treatment.
During hemodynamic instability within both the off-pump phases of on-pump CABG surgery (up to 8 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: A.P.J. Vlaar, Department of Intensive Care, Amsterdam UMC, location AMC, Amsterdam, the Netherlands

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2021

Primary Completion (Actual)

February 16, 2023

Study Completion (Actual)

March 16, 2023

Study Registration Dates

First Submitted

February 28, 2023

First Submitted That Met QC Criteria

April 7, 2023

First Posted (Actual)

April 20, 2023

Study Record Updates

Last Update Posted (Actual)

April 20, 2023

Last Update Submitted That Met QC Criteria

April 7, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NL76236.018.21
  • NL9449 (Registry Identifier: Netherlands Trial Registry)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlie the results reported in the final article including results in the text, tables, figures, and appendices, will be made available after deidentification.

IPD Sharing Time Frame

After 3 months and ending 36 months following article publication

IPD Sharing Access Criteria

Researchers who provide a methodologically sound proposal to achieve results in line with the proposed outcomes will be able to obtain IPD.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypotension

Clinical Trials on HPI guided treatment advice

Subscribe